Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts (Q39453452)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 22, 2011

Language	Label	Description	Also known as
English	Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts	scientific article published on October 22, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

1

object named as

Shaker A. Mousa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22024450

15 December 2024

author name string

Murat Yalcin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ran Meng

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Heng-Yuan Tang

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hung-Yun Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Dhruba J. Bharali

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22024450

15 December 2024

Faith B. Davis

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22024450

15 December 2024

Paul J. Davis

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22024450

15 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22024450

15 December 2024

publication date

22 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0169500211005162?httpAccept=text/xml

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

https://api.elsevier.com/content/article/PII:S0169500211005162?httpAccept=text/plain

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

39-45

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1016/J.STEROIDS.2006.11.014

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

3

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer

4

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer

5

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

6

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Molecular aspects of thyroid hormone actions

7

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

8

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

9

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated

10

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Thyroid hormone and angiogenesis

11

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells

12

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin

14

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Ligand binding to integrins

15

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Regulation of integrin activity and signalling

16

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF

17

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3

18

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor

19

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

20

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor

21

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.

22

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Rapid nongenomic effects of 3,5,3'-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways

23

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent

24

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system

25

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.

27

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.

28

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Metabolic effects of thyroid hormone derivatives.

29

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.

30

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).

31

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Cellular and molecular mechanisms of nicotine's pro-angiogenesis activity and its potential impact on cancer

35

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice

37

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma

39

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Hypothyroidism in patients with renal cell carcinoma: blessing or curse?

40

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study

41

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology

42

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

L-thyroxine and 3,5,3'-triiodothyronine concentrations in the chicken egg and in the embryo before and after the onset of thyroid function

43

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated

44

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

The pro-apoptotic action of stilbene-induced COX-2 in cancer cells: convergence with the anti-apoptotic effect of thyroid hormone.

45

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid subjects

46

1 reference

10.1016/J.LUNGCAN.2011.10.003

https://api.crossref.org/works/10.1016/J.LUNGCAN.2011.10.003

15 December 2024

Identifiers

10.1016/J.LUNGCAN.2011.10.003

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39453452&oldid=2287828313"